15.8
Dogwood Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
8.37
FY23:
4.17
FY24:
16.5
FY25:
8.43
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
77.8
FY25:
81.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
15.8
FY22:
8.37
FY23:
4.17
FY24:
94.3
FY25:
90.2
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.28
FY22:
1.04
FY23:
0.36
FY24:
3.18
FY25:
3.06
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
26.9
FY25:
12.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.5
FY22:
7.33
FY23:
3.81
FY24:
−10.1
FY25:
74.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
15.8
FY22:
8.37
FY23:
4.17
FY24:
–
FY25:
90.2
All amounts in millions USD